A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

NCT06388564 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Graft-versus-host-disease

Interventions

DRUG: Axatilimab
DRUG: Ruxolitinib
DRUG: Corticosteroids

Sponsor

Incyte Corporation